Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Advanced ovarian cancer: what should be the standard of care?

Goff BA.

J Gynecol Oncol. 2013 Jan;24(1):83-91. doi: 10.3802/jgo.2013.24.1.83. Epub 2013 Jan 8.

2.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
3.

Gynecological malignancies.

Schaebler DL, Schilder RJ, Young RC.

Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.

PMID:
8639401
4.

Upper abdominal cytoreduction and thoracoscopy for advanced epithelial ovarian cancer: unanswered questions and the impact on treatment.

Fleury AC, Kushnir CL, Giuntoli RL 2nd, Spirtos NM.

BJOG. 2012 Jan;119(2):202-6. doi: 10.1111/j.1471-0528.2011.03197.x. Epub 2011 Nov 15. Review.

5.

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction.

Bristow RE, Eisenhauer EL, Santillan A, Chi DS.

Gynecol Oncol. 2007 Feb;104(2):480-90. Epub 2006 Dec 12. Review.

PMID:
17166564
6.

Diagnosis and management of epithelial ovarian cancer.

Bhoola S, Hoskins WJ.

Obstet Gynecol. 2006 Jun;107(6):1399-410. Review.

PMID:
16738170
7.

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.

Vergote I, Amant F, Kristensen G, Ehlen T, Reed NS, Casado A.

Eur J Cancer. 2011 Sep;47 Suppl 3:S88-92. doi: 10.1016/S0959-8049(11)70152-6. Review.

PMID:
21944035
8.

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

Deraco M, Baratti D, Laterza B, Balestra MR, Mingrone E, Macrì A, Virzì S, Puccio F, Ravenda PS, Kusamura S.

Eur J Surg Oncol. 2011 Jan;37(1):4-9. doi: 10.1016/j.ejso.2010.11.004. Epub 2010 Nov 26. Review.

PMID:
21112721
9.

Update on first-line treatment of advanced ovarian carcinoma.

Kemp Z, Ledermann J.

Int J Womens Health. 2013;5:45-51. doi: 10.2147/IJWH.S30231. Epub 2013 Jan 25.

10.

Gynecologic malignancies.

Schilder RJ, Scher RM, Young RC.

Cancer Chemother Biol Response Modif. 1993;14:530-56. Review.

PMID:
8312118
11.

[Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].

Hatae M, Onishi Y, Nakamura T, Yamamoto H, Kusumoto M, Matsui T, Mihara K, Taniguchi H.

Gan To Kagaku Ryoho. 2001 Nov;28(12):1833-7. Review. Japanese.

PMID:
11729475
12.

Interval debulking surgery in advanced epithelial ovarian cancer.

Pecorelli S, Odicino F, Favalli G.

Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):573-83. Review.

PMID:
12413935
13.

Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.

Vergote IB, De Wever I, Decloedt J, Tjalma W, Van Gramberen M, van Dam P.

Semin Oncol. 2000 Jun;27(3 Suppl 7):31-6.

PMID:
10952124
15.

Comparative study of grade 3/4 toxicity associated with intraperitoneal chemotherapy administered after primary versus interval surgical debulking in ovarian cancer.

Le T, Latifah H, Jolicoeur L, Faught W, Weberpals J, Hopkins L, Fung-Kee-Fung M.

Int J Gynecol Cancer. 2011 Jul;21(5):811-5. doi: 10.1097/IGC.0b013e3182158640.

PMID:
21412160
16.

New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.

Muggia FM.

Semin Oncol. 2006 Dec;33(6 Suppl 12):S18-24. Review.

PMID:
17223446
17.

Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.

Ozols RF.

J Natl Compr Canc Netw. 2004 Sep;2 Suppl 2:S60-73. Review.

PMID:
19780247
18.

A critique of surgical cytoreduction in advanced ovarian cancer.

Covens AL.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):269-74.

PMID:
10985879
19.

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.

Elit L, Oliver TK, Covens A, Kwon J, Fung MF, Hirte HW, Oza AM.

Cancer. 2007 Feb 15;109(4):692-702. Review.

20.

Role of chemotherapy in the management of epithelial ovarian cancer.

Reed NS, Sadozye AH.

Expert Rev Anticancer Ther. 2005 Feb;5(1):139-47. Review.

PMID:
15757446

Supplemental Content

Support Center